Physiological effects and adjuvanticity of recombinant brushtail possum TNF-α

Immunology and Cell Biology

Volumn 77, Issue 1, 1999, Pages 28-33

  Wedlock, D N ^a   Goh, L P ^a   McCarthy, A R ^a   Midwinter, R G ^a   Parlane, N A ^a   Buddle, B M ^a  

^a AGRESEARCH   (New Zealand)

Author keywords

Adjuvant; Antibody; Cytokine; Pichia pastoris; Possum; TNF ; Yeast

Indexed keywords

KEYHOLE LIMPET HEMOCYANIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; HUMAN; IMMUNOMODULATION; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE COUNT; NONHUMAN; OPOSSUM; PICHIA PASTORIS; PROTEIN EXPRESSION; YEAST;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; DNA PRIMERS; HEMOCYANIN; HUMANS; OPOSSUMS; PICHIA; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033057669     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00793.x     Document Type: Article

References (18)

1. 1 Cowan PE, Tyndale-Biscoe CH. Australian and New Zealand mammal species considered to be pests or problems. Reprod. Fertil. Dev. 1997; 9: 27-36.
2. 2 Nohria A, Rubin RH. Cytokines as potential vaccine adjuvants. Biotherapy 1994; 7: 261-9.
3. 3 Heath AW. Cytokines as immunological adjuvants. In: Powell MF, Newman MJ (eds) Vaccine Design: The Subunit and Adjuvant Approach. New York: Plenum Press, 1995; 645-58.
4. 4 Lofthouse SA, Andrews AE, Nash AD, Bowles VM. Humoral and cellular responses induced by intradermally administered cytokine and conventional adjuvants. Vaccine 1995; 13: 1131-7.
5. 5 Lofthouse SA, Andrews AE, Barcham GJ, Nash AD. Parameters related to the application of recombinant ovine interleukin-1β as an adjuvant. Vaccine 1995; 13: 1277-87.
6. 6 Lin R, Tarr PE, Jones TC. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases. Clin. Infect. Dis. 1995; 21: 1339-49.
7. 7 Rothel JS, Seow H-F, Lightowlers MW et al. The use of recombinant ovine IL-1β and TNF-α as natural adjuvants and their physiological effects in vivo. Immunol. Cell Biol. 1998; 76: 167-72.
8. 8 Wedlock DN, Aldwell FE, Buddle BM. Molecular cloning and characterization of tumour necrosis factor alpha (TNF-α) from the Australian common brushtail possum, Trichosurus vulpecula. Immunol. Cell Biol. 1996; 74: 151-8.
9. 9 Aldwell FE, Wedlock DN, Buddle BM. Sequential activation of alveolar macrophages by IFN-γ and LPS is required for enhanced growth inhibition of virulent Mycobacterium bovis but not M. bovis BCG. Immunol. Cell Biol. 1997; 75: 161-6.
10. 10 Ito H, Fukuda Y, Murata K, Kimura A. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 1983; 153: 163-8.
11. 11 Flick DA, Gifford GF. Comparison of in vitro cell cytotoxic assays for tumour necrosis factor. J. Immunol. Methods 1984: 68: 167-75.
12. 12 Buddle BM, Aldwell FE, De Pfeffer A, Lisle G. Experimental Mycobacterium bovis infection in the brushtail possum (Trichosurus vulpecula): Pathology, haematology and lymphocyte stimulation responses. Vet. Microbiol. 1994; 38: 241-54.
13. 13 Buddle BM, Nolan A, McCarthy AR et al. Evaluation of three serological assays for the diagnosis of Mycobacterium bovis infection in brushtail possums. N.Z. Vet. J. 1995; 43: 91-5.
14. 14 Johnson J, Meyrick B, Jesmok G, Bringham KL. Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. J. Appl. Physiol. 1989; 66: 1448-54.
15. 15 Wedlock DN, Goh LP, Parlane NA, Buddle BM. Molecular cloning and physiological effects of brushtail possum interleukin-1β. Vet Immunol. Immunopathol. 1999 (in press).
16. 16 Beutler B, Cerami A. The history, properties, and biological effects of cachectin. Biochemistry 1988; 27: 7575-82.
17. 17 Ghiara P, Boraschi D, Nencioni L, Ghezzi P, Tagliabue A. Enhancement of in vivo immune response by tumor necrosis factor. J. Immunol. 1987; 139: 3676-9.
18. 18 Schijns VECJ, Claassen IJMT, Vermeulen AA, Horzinek MC, Osterhaus ADME. Modulation of antiviral immune responses by exogenous cytokines: Effects of tumour necrosis factor-α, interleukin-1β, interleukin-2 and interferon-γ on the immunogenicity of an inactivated rabies vaccine. J Gen. Virol. 1994; 75: 55-63.